Search Website Search Directory

UVM Cancer Center Logo

COLLEGE OF
MEDICINE
  • Home
  • Administration
    • Overview
    • Leadership Directory
    • Staff Directory
    • Member Directory
    • External Advisory Board
      • Emerging EAB Experience Program
    • Employment Opportunities
    • Events
  • For Members
    • Cancer Center Membership
    • Shared Resources
    • Clinical Trials Services
    • Extramural Funding
    • Intramural Funding
    • Transdisciplinary Teams (TDTs)
    • Protocol Review
      • Protocol Review
      • Submission Requirements
      • Procedures
      • Relationship to IRB
      • UVM Commons Tool
      • Protocol Review and Monitoring Committee Meetings
    • Membership Benefits
  • Clinical Care
    • Patients and Caregivers
    • Clinical Trials
      • Clinical Trials Office
      • Find A Cancer Trial
      • FAQs
      • Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
  • Research
    • Research Programs
  • Community Outreach
    • Community Advisory Board
    • Public Health
    • Women's Health and Cancer Conference
    • Cancer Center Ambassadors
  • Make a Gift
    • Give to the UVM Cancer Center
    • Ways to Give

  • Katie Queen, Ph.D. joins UVM Cancer Center
    December 5, 2023
  • Autoimmune Disease Linked to Increased Survival Rates in Blood Disorders Patients
    December 1, 2023
    Autoimmune disease is frequent in patients with myelodysplastic syndromes, but studies have been inconclusive about how the preexistence of autoimmunity affects survival in these patients. A new study by UVM Cancer Center member Diego Adrianzen Herrera, M.D. uses an epidemiologic analysis to clarify that issue.
  • Lung Cancer News for November, National Lung Cancer Awareness Month
    November 13, 2023
  • Covering Pain: Integrative Treatment Accessible to More Vermonters
    November 8, 2023
    A new collaboration between Vermont Medicaid and UVM Medical Center’s Comprehensive Pain Program allows Medicaid members with chronic pain to participate in complementary therapies including health coaching, massage, yoga, nutrition, acupuncture, and meditation. This pilot is an important step toward eliminating disparities in access to effective, integrative care for pain.
  • Diego Adrianzen Herrera, MD Appointed Associate Director of Diversity, Equity, and Inclusion
    October 19, 2023
  • Lester-Coll Quoted in Renal & Urology News Article on SBRT to Treat Prostate Cancer
    October 16, 2023
    (OCTOBER 16, 2023) Nataniel Lester-Coll, M.D., assistant professor of radiation oncology at the University of Vermont Medical Center, commented to Renal & Urology News about a study of stereotactic body radiation therapy (SBRT) as a treatment for prostate cancer.
    Read full story from Renal & Urology News
  • UVMCC partners with Nulhegan Band of the Coosuk Abenaki Nation
    October 16, 2023
    To reduce barriers to skin cancer screening, the University of Vermont Cancer Center works with the UVM Cancer Center’s community advisory board member, Chief Donald Stevens, tribal leader for the Nulhegan Band of the Coosuk Abenaki Nation to bring skin checks out to communities in Vermont.
  • Holcombe Comments to WCAX on Women’s Health and Cancer Conference
    October 2, 2023
    (OCTOBER 2, 2023) Randall Holcombe, M.D., M.B.A., director of the UVM Cancer Center, commented to WCAX about the annual Women’s Health and Cancer Conference held at UVM on September 29.
    Read full story from WCAX-TV
  • 26th Annual Women’s Health and Cancer Conference
    September 25, 2023
  • Cunniff Lab Data Shared at World Conference on Lung Cancer, New Sarawak Tribune Reports
    September 18, 2023
    (SEPTEMBER 18, 2023) Larner’s Cunniff Laboratory, headed by Brian Cunniff, Ph.D., assistant professor of pathology and laboratory medicine, was part of a collaboration that recently shared new preclinical data at the IASLC 2023 World Conference on Lung Cancer in Singapore, the (Malaysia) New Sarawak Tribune reported.
    Read full story from New Sarawak Tribune (Malaysia)
  • New study in Science Advances reveals insights into the regulation of glutathione
    September 13, 2023
    Research by Yvonne Janssen-Heininger, Ph.D., and Reem Aboushousha, Ph.D, uncovered a novel facet of glutaredoxin, a prominent player in humans’ antioxidant defense system . The findings bear substantial implications in the field of cancer biology.
  • Summer Scholars: Medical Students Dive Into Research
    September 12, 2023
    Each summer, many rising second-year medical students engage in clinical, basic science or health policy-related research projects under the guidance of expert faculty. The students choose their topics based on personal passions and immerse themselves in projects tackling medical puzzles and unmet health needs. Engaging in research can be among the most valuable experiences during a medical education.
  • Nataniel Lester-Coll, MD presents at first-ever ASTRO "Refresher" meeting in Latin America
    September 12, 2023
  • The Butler Foundation surpasses $80,000 in gifts to support Mesothelioma Research at the University of Vermont Cancer Center
    August 30, 2023
  • Hope Lodge: A Home Away From Home for UVM Cancer Patients
    August 25, 2023
  • Lady Glaucomflecken to Speak at 2023 Women’s Health and Cancer Conference
    August 8, 2023
    Kristin Flanary, known internationally as her social media alter ego, Lady Glaucomflecken, is on a mission to make health care a little more human. Through storytelling, her keynote address on September 29 at the Women’s Health and Cancer Conference will highlight her perspective as a caregiver and “co-survivor” of her husband’s two cancer occurrences and sudden cardiac arrest.
  • Cunniff Presents New Cancer Research at iMig Conference
    August 3, 2023
    (AUGUST 3, 2023) At the 2023 International Mesothelioma Interest Group (iMig) conference in June, Brian Cunniff, Ph.D., assistant professor of pathology, presented early experience with “an exciting new therapeutic option for patients suffering with mesothelioma” to a global audience of clinicians, scientists, and allied professionals, according to Business Wire.
    Read full story from Business Wire
  • New Drug Gives Quality-of-Life Boost to Cancer Patients with Deadly Blood Clots
    July 11, 2023
    Thanks to positive results from a new clinical trial in which the UVM Cancer Center and Chris Holmes, M.D., Ph.D., professor of medicine, played a role, the five to 25 percent of cancer patients who develop venous thrombosis will no longer need to inject themselves with a blood thinner.
  • Kanayo Ikeh Named UVM Cancer Center Juckett Scholar
    June 28, 2023
    This summer, 20 summer scholars were awarded $4,000 stipends to deepen their engagement, hone their skills, and drive towards new discoveries under the guidance of a UVM Cancer Center mentor. Among the group is Kanayo Ikeh, this year’s 2023 Juckett Summer Student Scholar.
  • Patriot Star’s Foundation Makes Grants Available to New England Cancer Patients with Financial Need
    June 22, 2023
    Former New England Patriot and three-time Super Bowl champion Joe Andruzzi visited the UVM Cancer Center’s patients and care teams on June 22, 2023 as part of a road trip celebrating his namesake Joe Andruzzi Foundation’s 15th anniversary.
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
News Sources
  • HealthSource (University of Vermont Medical Center)
  • Larner College of Medicine News
Accessibility | Privacy/Terms of Use
Copyright 2023 | Burlington, VT